• Seeking Alpha

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

Seeking Alpha / 1 hour ago 1 Views

60 Degrees Pharma reports Q1 2025 revenue up 55% to $163.6K, gross profit up 124%, driven by Arakoda sales.
Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Globus Medical Announces $500 Million Share Repurchase Program
Next post
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation

Comments

Just Posted

  • Rubicon Organics to Report Q1 2025 Results

    3 hours from now

  • BFCM - Issuer Call Notice - SERIES 85 (ISIN CODE XS0207764712)

    3 hours from now

  • TruGolf Reports First Quarter 2025 Financial Results Q1 2025 Sales Grow 7.5% Over Q1 2024

    3 hours from now

  • Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

    2 hours from now

  • Brady Corporation declares regular dividend to shareholders

    2 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1678

Categories

  • Seeking Alpha 1678

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts